Adapting to Change: Shifts in Cystic Fibrosis Testing and Treatment

This talk provides an in-depth exploration of the evolving landscape of cystic fibrosis (CF) care, focusing on recent advances in testing and treatment. The presentation discusses advances in genetic analysis and modulator therapy, which have led to highly targeted and personalized treatments for CF patients. The session then highlights changes in newborn screening, which enable earlier CF diagnosis and intervention, helping to improve patient outcomes from infancy. The speaker will also discuss trends and their implications for diagnosing and monitoring CF by analyzing data from sweat chloride testing at Seattle Children’s Hospital. Updated guidelines for CF testing and treatment are also presented, underscoring the importance of adapting to new standards in clinical practice. Lastly, the session delves into barriers to equitable CF care, especially for diverse populations who may face challenges accessing specialized testing and treatment. After viewing this lecture, participants should be able to: 1. Give an update on the testing and treatment options available for people with cystic fibrosis (CF). 2. Understand trends in NBS testing algorithms that screen for CF. 3. Examine the barriers to equitable treatment and access to care for diverse CF populations. Lisa Johnson, PhD Assistant Professor, Clinical Chemistry Department of Laboratory Medicine & Pathology Seattle Children's Hospital University of Washington 11/06/24 The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.